Complex PCI: Complex Characteristics Impact Results

Patients with a bigger number of complex anatomical characteristics that increase PCI complexity have worse results at one-year followup.

Angioplastias complejas

These data come from a large multicenter study (e-Ultimaster) recently published in EuroIntervention.

The more complex the characteristics, the greater the increase in events. 

It is important to see past the obvious anatomical challenges (bifurcations, calcification, multivessel disease, etc.) and keep a wider perspective. A patient is much more than their coronary arteries. Complexity procedure also contributes (atherectomy, hemodynamic support).

PCI complexity is not a binary variable. There is an infinite range of greys in between with a dose/response outcome curve. Each point contributes to complexity and to increased hazard ratio. 


Read also: Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks.


In this study in particular, the authors define complexity based on factors used by the 2017  European guidelines for dual antiplatelet therapy. These factors give us a general idea, but we still need a standardized definition. 

The analysis included 35839 patients (mean age 64) undergoing coronary PCI between 2014 and 2018 with Ultimaster DES.

Risk characteristics were: multivessel disease, at least three stents, at least three lesions, bifurcations with at least 2 stents, total length covered with stents of 60 mm or more and chronic total occlusion. 27.3% of patients presented at least one risk characteristic but the vast majority presented more than one (73.3%), most frequently multivessel PCI, with 16.3%.


Read also: Death, Stroke, and Hospitalization while Waiting for TAVR.


Patients with more risk characteristics tended to be older, have more comorbidities, and chronic coronary syndrome. 

At one-year followup, target vessel failure rate was significantly higher in patients with at least one risk characteristic vs. patients with no risk characteristics for both the combined end point and its separate components. End points such as cardiac death (HR 1.28; CI 95% 1.05-1.55), target vessel related MI (HR 1.48; CI 95% 1.18-1.86) and clinically driven revascularization (HR 1.42; CI 95% 1.20-1.68) were associated to PCI complexity. 

Increased risk characteristics involve increased adverse events rate which, in addition to the ones mentioned, includes stent thrombosis. 


Read also: Long-Term Cardiovascular Effects of COVID-19.


Bifurcations increased target vessel failure rate by close to 100% (HR 2.01; 95% CI 1.55-2.62).

Bleeding risk resulted similar in both groups at 30 days, but after a year, patients with complex PCI characteristics had more bleeding events. 

This might be explained because some risk factors are common to both ischemic and bleeding events, such as hypertension, diabetes, kidney failure and old age. 

impact-of-coronary-lesion-complexity-in-percutaneous-coronary-intervention-one-y

Original Title: Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry.

Reference: Mohamed MO et al. EuroIntervention. 2020;16:603-612.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...